The Royal Brompton Hosptial Are Seeking DCM Patients for a New Dilated Cardiomyopathy Study TRED Researchers at the Royal Brompton Hospital, and the NHLI (National Heart and Lung Institute) are to begin a new BHF-funded dilated cardiomyopathy study. They are currently inviting patients with a previous DCM diagnosis, whose heart function has recovered after a […]

Stem Cell Implants Could Be The Key – Reversing Heart Failure Breakthrough. In a ‘astonishing’ new trial, eleven heart attack patients with stage 3 heart failure, and expected to die withing two years,  are today fit and healthy after scientists regenerated their damaged hearts with stem cells, in a ground-breaking, heart failure breakthrough, phase IIa, […]

  Electromechanical cardioplasty using a wrapped elasto-conductive epicardial mesh Electromechanical hug for the heart A mesh that wraps around the heart can strengthen a failing heart, a new study shows, in rats Interesting news for Cardiac Resyncronisation Therapy; Jinkyung Park from the Institute for Basic Science in Seoul, South Korea, and colleagues design a soft, elastic […]

The Pumping Marvellous Foundation today added the following comment following NHS England Announcement on the fufture of congenital heart disease services, and transfer of selected CHD surgical and interventional cardiology: “Our concerns are for patients and how this will affect them, with increased cost and length of travel” – The Pumping Marvellous Foundation Read the […]

St. Jude Medical Expand Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies Adding SyncAV™ CRT technology to the company’s comprehensive heart failure offerings provides further advantages to the St. Jude Medical portfolio to support physicians seeking new treatment options for heart failure patients St. […]

New Anti Diabetes Drug Trials launched to determine benefits for Cardiovascular Health Researchers at the University of Dundee have launched a series of projects to determine whether a new class of anti diabetes drug could also be used to treat heart disease. Diabetes and heart disease are frequently seen together and can be a potentially […]

For MedTech Week, leader of HF advocacy and the heart failure patient conversation, Nick Hartshorne Evans explains how and why patient-led heart failure communities are driving access to the latest heart failure information, innovations and therapies MedTech Week: How to Enable Access to Innovation in Heart Failure for Patients? QUESTION: As an active leader in […]

    Nick Hartshorne Evans’ Voices Concern in Open Letter to The Telegraph – Treating Heart Failure Following news from the recent studies about a 36% rise in heart failure hospitalisations in the past decade, Pumping Marvellous founder, Nick Hartshorne Evans’ sends an open letter to The Telegraph raising his concerns about the growth and […]

Detecting fluid retention in patients early is important to prevent their heart failure from getting worse. Nurses who are trained in the use of handheld pocket ultrasound devices can dispense diuretic drugs more precisely. These medications prevent harmful fluid retention in patients with heart failure. Researchers at Levanger Hospital and the Norwegian University of Science […]

Medtronic’s ICDs with Atrial Fibrillation Detection Win FDA Approval Medtronic plc today announced it has received U.S. Food and Drug Administration, FDA approval for the Visia AF MRI(TM) SureScan® and Visia AF(TM) single-chamber implantable cardioverter defibrillators (ICDs). The Visia AF devices can detect previously undiagnosed and/or asymptomatic atrial fibrillation (AF) and monitor recurrent AF, while […]

NICE Publish Guidance for Sacubitril valsartan NICE gives green light to new heart failure drug set to benefit 100,000 people with common heart condition In guidance published today NICE has recommended new heart failure drug sacubitril valsartan (Entresto, Novartis), the first drug of its kind, as an option for some people with heart failure. The […]

NICE says ‘Yes’ to new heart failure medicine, Entresto™ (sacubitril/valsartan), in final recommendation * NICE recognises Entresto sacubitril valsartan as an innovative and cost-effective treatment in the management of symptomatic chronic heart failure with reduced ejection fraction * Heart failure affects around 550,000 people in the UK and has a poor prognosis for many patients, […]

NICE Publish Final Appraisal Determination for Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction National Institute for Health and Care Excellence (NICE) Recommendations in Final Appraisal Determination for Sacubitril valsartan Recommendations 1.1 Sacubitril valsartan is recommended as an option for treating symptomatic chronic heart failure with reduced ejection fraction, only in people:  […]

Novartis’ new heart failure medicine, Entresto™, sacubitril valsartan accepted for use in Scotland by the Scottish Medicines Consortium  SMC recognised sacubitril valsartan represents a new therapeutic option for adult patients with symptomatic chronic heart failure with reduced ejection fraction1and may be used instead of the current gold standard treatment for the condition  Heart […]

Ohio State Evaluates First Transcatheter Implant for Diastolic Heart Failure  For the first time in the U.S., a clinical trial is underway that’s evaluating a transcatheter implant device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center. Diastolic […]